For the first time, researchers from University of Calgary have found scientific basis of MS remission in pregnancy. Animal study involving pregnant mice showed increased level of Prolactin hormone during pregnancy promotes myelin production and thereby protect against demyelinating episodes. Although it is debatable whether prolactin has any potential for MS therapy, scientists expect to conduct clinical trials in coming years.
Ref.:
1. EurekAlert! Feb 20, 2007 post
2. Journal of Neuroscience Feb 21, 2007 issue
Recent update in MS:
- FDA Approves Resumed Marketing of Natalizumab (Tysabri) Under a Special Distribution Program - FDA news June 5, 2006
0 comments:
Post a Comment